MX2013004406A - Tratamiento de diabetes mellitus usando inyecciones de insulina administradas con intervalos variables de inyeccion. - Google Patents

Tratamiento de diabetes mellitus usando inyecciones de insulina administradas con intervalos variables de inyeccion.

Info

Publication number
MX2013004406A
MX2013004406A MX2013004406A MX2013004406A MX2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A MX 2013004406 A MX2013004406 A MX 2013004406A
Authority
MX
Mexico
Prior art keywords
treating diabetes
insulin injections
injection intervals
injections administered
diabetes melitus
Prior art date
Application number
MX2013004406A
Other languages
English (en)
Other versions
MX366314B (es
Inventor
Thue Johansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MX2013004406A publication Critical patent/MX2013004406A/es
Publication of MX366314B publication Critical patent/MX366314B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

La presente invención se refiere a métodos para el tratamiento de una condición o enfermedad donde la administración de insulina será de beneficio, que comprenden administrar a un paciente en necesidad de lo mismo, dosis eficaces de una insulina, análogo de insulina o derivado de esto, que exhibe un perfil prolongado de acción, en donde las dosis se administran a intervalos de duración variable.
MX2013004406A 2010-10-27 2011-10-27 Uso de derivados de insulina por inyecciones con intervalos variables. MX366314B (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US40720610P 2010-10-27 2010-10-27
EP11170366 2010-10-27
EP10189115 2010-10-27
US201161498645P 2011-06-20 2011-06-20
PCT/EP2011/068870 WO2012055967A2 (en) 2010-10-27 2011-10-27 Treating diabetes melitus using insulin injections administered with varying injection intervals

Publications (2)

Publication Number Publication Date
MX2013004406A true MX2013004406A (es) 2013-05-17
MX366314B MX366314B (es) 2019-07-05

Family

ID=43571114

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004406A MX366314B (es) 2010-10-27 2011-10-27 Uso de derivados de insulina por inyecciones con intervalos variables.

Country Status (11)

Country Link
US (1) US20130261051A1 (es)
EP (1) EP2632478B1 (es)
KR (1) KR20130139297A (es)
CN (1) CN103167878A (es)
AU (2) AU2011322495A1 (es)
CA (1) CA2815419A1 (es)
MX (1) MX366314B (es)
PL (1) PL2632478T3 (es)
RS (1) RS59423B1 (es)
SI (1) SI2632478T1 (es)
WO (1) WO2012055967A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
KR101939557B1 (ko) 2008-10-17 2019-01-17 사노피-아벤티스 도이칠란트 게엠베하 인슐린과 ｇｌｐ－1 효능제의 병용물
AU2009309623B9 (en) 2008-10-30 2014-10-02 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
AU2010317994B2 (en) 2009-11-13 2014-03-06 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist and methionine
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
CN103179978A (zh) 2010-08-30 2013-06-26 赛诺菲-安万特德国有限公司 Ave0010用于制造供治疗2型糖尿病用的药物的用途
JP6049625B2 (ja) 2010-10-27 2016-12-21 ノヴォ ノルディスク アー／エス 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
JP6367115B2 (ja) 2011-08-29 2018-08-01 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ２型糖尿病患者の血糖コントロールに使用する組合せ医薬
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US9884094B2 (en) 2012-05-01 2018-02-06 Novo Nordisk A/S Method of treating diabetes mellitus
JP6755175B2 (ja) * 2013-03-20 2020-09-16 ノヴォ ノルディスク アー／エス インスリン投薬レジメン
EP2983697B1 (en) 2013-04-03 2018-10-31 Sanofi Treatment of diabetes mellitus by long acting formulations of insulins
EP2991672A1 (en) 2013-04-30 2016-03-09 Novo Nordisk A/S Novel administration regime
KR20160065126A (ko) * 2013-10-07 2016-06-08 노보 노르디스크 에이/에스 인슐린 유사체의 신규한 유도체
NZ733670A (en) 2014-12-12 2021-12-24 Sanofi Aventis Deutschland Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
WO2020225129A1 (en) * 2019-05-03 2020-11-12 Diavein Method for treating diabetes and associated disorders with vascular electrical stimulation therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
NZ222907A (en) 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
AU641631B2 (en) 1988-12-23 1993-09-30 Novo Nordisk A/S Human insulin analogues
PT93057B (pt) 1989-02-09 1995-12-29 Lilly Co Eli Processo para a preparacao de analogos da insulina
US20040138099A1 (en) * 2002-11-29 2004-07-15 Draeger Eberhard Kurt Insulin administration regimens for the treatment of subjects with diabetes
DK2275439T3 (da) * 2003-08-05 2014-05-12 Novo Nordisk As Hidtil ukendte insulinderivater
CA2531988C (en) 2003-08-05 2016-06-28 Novo Nordisk A/S Novel insulin derivatives
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
EP2386572B1 (en) * 2006-05-09 2015-07-08 Novo Nordisk A/S Insulin derivative
US9034818B2 (en) 2007-06-13 2015-05-19 Novo Nordisk A/S Pharmaceutical formulations comprising an insulin derivative
AU2009309623B9 (en) * 2008-10-30 2014-10-02 Novo Nordisk A/S Treating diabetes melitus using insulin injections with less than daily injection frequency

Also Published As

Publication number Publication date
CN103167878A (zh) 2013-06-19
MX366314B (es) 2019-07-05
AU2016202917B2 (en) 2017-07-20
SI2632478T1 (sl) 2019-11-29
WO2012055967A2 (en) 2012-05-03
WO2012055967A3 (en) 2012-06-21
AU2011322495A1 (en) 2013-04-11
AU2016202917A1 (en) 2016-05-26
CA2815419A1 (en) 2012-05-03
US20130261051A1 (en) 2013-10-03
KR20130139297A (ko) 2013-12-20
PL2632478T3 (pl) 2020-03-31
EP2632478B1 (en) 2019-07-24
RS59423B1 (sr) 2019-11-29
EP2632478A2 (en) 2013-09-04

Similar Documents

Publication Publication Date Title
MX2013004406A (es) Tratamiento de diabetes mellitus usando inyecciones de insulina administradas con intervalos variables de inyeccion.
PL385586A1 (pl) Nowe analogi insuliny o przedłużonym działaniu
EA201400030A1 (ru) Способ непрерывного подкожного введения инсулина с использованием фермента, разрушающего хиалуронан
PH12015500407B1 (en) Methods of treating hypertriglyceridemia
EA201201657A1 (ru) Лечение диабета
MY167234A (en) Novel glucagon analogues
NI201000105A (es) Régimen de dosificación asociado con ésteres de paliperidona inyectables de acción prolongada.
EA201370178A1 (ru) Стабильные составы для парентеральной инъекции пептидных лекарственных средств
BR112013024973A2 (pt) prevenção de hipoglicemia em pacientes com diabetes mellitus do tipo 2
EA201300522A1 (ru) Фармацевтические комбинации для лечения метаболических нарушений
MX2013011175A (es) Analogos de glucagon novedosos.
MX2013013242A (es) Combinacion farmaceutica para mejorar el control glucemico como terapia adicional a la insulina basal.
MX2019007779A (es) Metodo cosmetico para el tratamiento o reduccion de paniculopatia edemato-fibroesclerotica (pefe).
CO2018000196A2 (es) Agente terapéutico para tratar el síndrome de hunter y método de tratamiento
AR082312A1 (es) Una composicion farmaceutica de combinacion para tratar diabetes y desordenes metabolicos
PH12015501931A1 (en) Treatment of diabetes mellitus by long-acting formulations of insulins
MX2013009842A (es) Composicion que comprende receptor gamma activado por proliferador de peroxisoma.
MD20150120A2 (ro) Tratamentul bolilor neurodegenerative şi miopatice de agregare proteică prin administrarea parenterală a trehalozei
EA201491702A1 (ru) Оптимизированные терапевтические агенты для подкожного введения
EA201691420A1 (ru) Композиции енолазы 1 (eno1) и их применение
MX2016000220A (es) Regulacion del metabolismo de glucosa usando anticuerpos anti-cgrp.
BR112013010345A2 (pt) tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
EA201391063A1 (ru) Аполипопротеин a-iv в качестве антидиабетического пептида
WO2014018763A3 (en) Method of treating type i diabetes using apolipoprotein aiv
BR112022004723A2 (pt) Formulações de insulina e glucagon injetáveis por via subcutânea e métodos de administração

Legal Events

Date Code Title Description
GD Licence granted
FG Grant or registration